LYPHF Stock - Luye Pharma Group Ltd.
Unlock GoAI Insights for LYPHF
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Free 14-day trial • No credit card required
Premium members get real-time SMS alerts
Financial Statements
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $6.06B | $6.14B | $5.98B | $5.20B | $5.54B |
| Gross Profit | $4.04B | $4.20B | $4.14B | $3.40B | $3.99B |
| Gross Margin | 66.7% | 68.4% | 69.2% | 65.3% | 72.0% |
| Operating Income | $1.29B | $1.03B | $1.21B | $386.99M | $1.42B |
| Net Income | $471.89M | $532.61M | $604.81M | $-144,783,000 | $706.59M |
| Net Margin | 7.8% | 8.7% | 10.1% | -2.8% | 12.8% |
| EPS | $0.02 | $0.14 | $0.17 | $-0.04 | $0.22 |
Luye Pharma Group Ltd., an investment holding company, develops, produces, markets, and sells pharmaceutical products worldwide. The company offers Lipusu for ovarian and breast cancer; CMNa, a chemical sensitizer for cancer radiotherapy; Tiandida for ovarian or non-small cell lung cancer; Boyounuo, an injection for the treatment of various types of cancers and other solid tumors; and Xuezhikang, a lipid regulating drug for the treatment of hypercholesterolaemia. It also provides Maitongna for cerebral edema swelling by trauma or surgery, and for venous reflux disorders; Beixi, an acarbose capsule for Type 2 diabetes; Rivastigmine Transdermal Patch for the treatment of Alzheimer's disease; Fentanyl Transdermal Patch for cancer pain; Buprenorphine Transdermal Patch for chronic pain; and Seroquel and Seroquel XR for the treatment of schizophrenia and manic episodes of bipolar affective disorders, In addition, the company offers Rykindo, an injection for the treatment of schizophrenia; Tiandixin used as an adjuvant therapy for malignant tumors, hydrothorax and ascites, and respiratory infections; Yitaida for acute promyelocytic leukemia and liver cancer; Lutingnuo, a glutathione injection for toxicity and injuries caused by ionizing radiation; and Beitangning, a pioglitazone hydrochloride capsule to control blood glucose. Further, it offers Nuosen for acute upper digestive tract hemorrhage; Sailimai for the treatment of diarrhea; Apleek Transdermal Patch for contraception; Sidinuo for osteoporosis; Glucosamine hydrochloride tablets for osteoarthritis; Oulai, a compound sodium aescinate gel for local swelling; Oukai for the treatment of soft tissue swelling and venous edema; and Fengshiye for patients who have pains in bones, joints, and limbs. The company distributes and sells pharmaceutical drugs; and manufactures and sells biopharmaceutical products. Luye Pharma Group Ltd. was founded in 1994 and is headquartered in Yantai, the People's Republic of China.
Visit WebsiteEarnings History & Surprises
LYPHFEPS Surprise History
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q3 2025 | Aug 28, 2025 | $0.01 | $0.01 | +18.8% | ✓ BEAT |
Q1 2025 | Mar 27, 2025 | $0.02 | $0.00 | -79.7% | ✗ MISS |
Q3 2024 | Aug 28, 2024 | — | $0.01 | — | — |
Q2 2024 | Apr 8, 2024 | $0.01 | $0.01 | +1.9% | ✓ BEAT |
Q2 2023 | Jun 30, 2023 | $0.00 | $0.01 | +35.3% | ✓ BEAT |
Q1 2023 | Mar 29, 2023 | $0.01 | $0.01 | +48.4% | ✓ BEAT |
Q3 2022 | Aug 29, 2022 | $0.02 | $0.01 | -34.3% | ✗ MISS |
Q1 2022 | Mar 29, 2022 | $0.01 | $-0.02 | -266.2% | ✗ MISS |
Q3 2021 | Aug 29, 2021 | $0.02 | $0.02 | -19.5% | ✗ MISS |
Q1 2021 | Mar 31, 2021 | $0.04 | $0.01 | -79.8% | ✗ MISS |
Q3 2020 | Aug 27, 2020 | $0.04 | $0.02 | -32.4% | ✗ MISS |
Q1 2020 | Mar 26, 2020 | $0.04 | $0.03 | -22.8% | ✗ MISS |
Q3 2019 | Aug 28, 2019 | — | $0.03 | — | — |
Q2 2019 | May 23, 2019 | — | $0.04 | — | — |
Q3 2018 | Aug 26, 2018 | — | $0.03 | — | — |
Q1 2018 | Mar 26, 2018 | — | $0.03 | — | — |
Q3 2017 | Aug 28, 2017 | — | $0.02 | — | — |
Q2 2017 | Apr 7, 2017 | — | $0.02 | — | — |
Q3 2016 | Aug 29, 2016 | — | $0.02 | — | — |
Q1 2016 | Mar 29, 2016 | — | $0.02 | — | — |
Latest News
Frequently Asked Questions about LYPHF
What is LYPHF's current stock price?
What is the analyst price target for LYPHF?
What sector is Luye Pharma Group Ltd. in?
What is LYPHF's market cap?
Does LYPHF pay dividends?
Similar Stocks
Healthcare SectorExplore stocks similar to LYPHF for comparison